000			02106 a2200613 4500
005			20250518042700.0
264		0	_c20200518
008			202005s 0 0 eng d
022			_a1097-0142
024	7		_a10.1002/cncr.32079 _2doi
040			_aNLM _beng _cNLM
100	1		_aHollis, Robert L
245	0	0	_aHigh EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum. _h[electronic resource]
260			_bCancer _c08 2019
300			_a2772-2781 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBRCA2 Protein _xgenetics
650	0	4	_aBevacizumab _xadministration & dosage
650	0	4	_aCarboplatin _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aComputer Simulation
650	0	4	_aCystadenocarcinoma, Serous _xdrug therapy
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Proteins _xgenetics
650	0	4	_aNuclear Proteins _xgenetics
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aRepressor Proteins _xgenetics
650	0	4	_aReproducibility of Results
700	1		_aChurchman, Michael
700	1		_aMichie, Caroline O
700	1		_aRye, Tzyvia
700	1		_aKnight, Laura
700	1		_aMcCavigan, Andrena
700	1		_aPerren, Timothy
700	1		_aWilliams, Alistair R W
700	1		_aMcCluggage, W Glenn
700	1		_aKaplan, Richard S
700	1		_aJayson, Gordon C
700	1		_aOza, Amit
700	1		_aHarkin, D Paul
700	1		_aHerrington, C Simon
700	1		_aKennedy, Richard
700	1		_aGourley, Charlie
773	0		_tCancer _gvol. 125 _gno. 16 _gp. 2772-2781
856	4	0	_uhttps://doi.org/10.1002/cncr.32079 _zAvailable from publisher's website
999			_c29754989 _d29754989